(Q35901976)

11 August 2017

0 references

1 reference

title

Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women (English)

1 reference

11 August 2017

1 reference

1 reference

1 reference

2

Sara A Quandt

1 reference

11 August 2017

author name string

Socrates E Papapoulos

1

1 reference

11 August 2017

Uri A Liberman

3

1 reference

11 August 2017

Marc C Hochberg

4

1 reference

11 August 2017

Desmond E Thompson

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

21 September 2004

1 reference

Osteoporosis International

11 August 2017

published in

1 reference

11 August 2017

volume

16

1 reference

11 August 2017

issue

5

1 reference

11 August 2017

page(s)

468-474

1 reference

Design of the Fracture Intervention Trial

11 August 2017

cites work

1 reference

12 December 2020

Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

1 reference

12 December 2020

Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group and the Cochrane Applicability Methods Working Group

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

12 December 2020

Alendronate for the Treatment of Osteoporosis in Men

1 reference

12 December 2020

Epidemiology and outcomes of osteoporotic fractures

1 reference

12 December 2020

Alendronate increases bone mass and reduces bone markers in postmenopausal African-American women

1 reference

12 December 2020

Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups.

1 reference

12 December 2020

Prevalence of low femoral bone density in older U.S. women from NHANES III

1 reference

12 December 2020

Why do we need systematic overviews of randomized trials?

1 reference

12 December 2020

Evidence-based management of patients with osteoporosis

1 reference

12 December 2020

A comprehensive review of treatments for postmenopausal osteoporosis

1 reference

12 December 2020

Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group

1 reference

12 December 2020

Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

12 December 2020

Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers

1 reference

12 December 2020

Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women

1 reference

12 December 2020

The worldwide problem of osteoporosis: insights afforded by epidemiology

1 reference

12 December 2020

10.1007/S00198-004-1725-Z

Identifiers

DOI

1 reference

11 August 2017

1 reference